SREBF1 and fatty liver disease: Oxymatrine inhibited the transcription factor sterol regulatory element binding transcription factor 1 (SREBF1) and Peroxisome Proliferator-activated Receptor α (PPARα) and suppressed hepatic steatosis in non-alcoholic fatty liver disease (9, 10).